|
Title
|
Published
|
Price
|
|
Companion Diagnostics Partnering Terms and Agreements
By: Current Partnering
... and analysis of how and why companies enter companion diagnostics partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors ...
|
more...
Search inside this report
|
2/1/2012
|
$2,695.00
|
|
Diagnostics Partnering Terms and Agreements
By: Current Partnering
... how and why companies enter diagnostic partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors diagnostic technology or product candidates. These ...
|
more...
|
2/1/2012
|
$2,695.00
|
|
Biomarker Partnering Terms and Agreements
By: Current Partnering
... analysis of how and why companies enter biomarker partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors biomarker technology. ...
|
more...
Search inside this report
|
2/1/2012
|
$2,695.00
|
|
Pharmacogenomics Partnering Terms and Agreements
By: Current Partnering
... analysis of how and why companies enter pharmacogenomic partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors pharmacogenomic technology. ...
|
more...
Search inside this report
|
2/1/2012
|
$2,695.00
|
|
Practical Guide to Finding Partners
By: Current Partnering
... managing of discussions through to deal negotiation. In addition, the report provides a detailed overview of the activities a business development executive and a company should be undertaking to build and maintain an extensive contact ...
|
more...
Search inside this report
|
2/1/2012
|
$995.00
|
|
Partnering Yearbook 2012
By: Current Partnering
... gain insight into the partnering activities of the past year. The report allows you to view all the partnering, alliances deals announced worldwide. Chapter 1 provides an introduction to the report, whilst chapter 2 provides ...
|
more...
|
1/1/2012
|
$2,995.00
|
|
Partnering and M&A Yearbook 2012
By: Current Partnering
... will effectively and efficiently gain insight into the partnering activities of the past year. The report allows you to view all the partnering, alliances and M&A deals announced worldwide. Chapter 1 provides an introduction to ...
|
more...
|
1/1/2012
|
$3,495.00
|
|
M&A Yearbook 2012
By: Current Partnering
... gain insight into the partnering activities of the past year. The report allows you to view all the M&A deals announced worldwide. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an ...
|
more...
Search inside this report
|
1/1/2012
|
$2,995.00
|
|
Vaccine Partnering Terms and Agreements
By: Current Partnering
... analysis of how and why companies enter vaccine partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors vaccine technology. ...
|
more...
Search inside this report
|
10/1/2011
|
$2,695.00
|
|
Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 5th edition
By: Current Partnering
... This report provides details of the latest co-promotion and co-marketing agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully revised and updated, the report provides details of co-promotion and co-marketing agreements from 2005 to ...
|
more...
Search inside this report
|
7/1/2011
|
$2,995.00
|
|
Personalized Medicine Partnering Terms & Agreements
By: Current Partnering
... understanding and analysis of how and why companies enter personalized medicine partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the ...
|
more...
Search inside this report
|
4/1/2011
|
$4,995.00
|
|
Pharmacogenomic Partnering Terms and Agreements
By: Current Partnering
... analysis of how and why companies enter pharmacogenomic partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors pharmacogenomic technology. ...
|
more...
Search inside this report
|
4/1/2011
|
$2,695.00
|
|
Biomarker Partnering Terms and Agreements
By: Current Partnering
... analysis of how and why companies enter biomarker partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors biomarker technology. ...
|
more...
Search inside this report
|
4/1/2011
|
$2,695.00
|
|
Companion Diagnostics Partnering Terms and Agreements
By: Current Partnering
... understanding and analysis of how and why companies enter companion diagnostics partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the ...
|
more...
Search inside this report
|
4/1/2011
|
$2,695.00
|
|
Partnering and M&A Agreements in Pharma and Biotech Yearbook 2010
By: Current Partnering
... 2010. Using this report, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report allows you to view all the partnering, alliances and M&A deals announced worldwide. Chapter ...
|
more...
Search inside this report
|
1/1/2011
|
$2,995.00
|
|
Bioinformatics Partnering Terms and Agreements
By: Current Partnering
... analysis of how and why companies enter bioinformatics partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors vaccine technology. ...
|
more...
Search inside this report
|
1/1/2011
|
$2,695.00
|
|
Asset Purchase Terms and Agreements in Pharma, Biotech and Diagnostics, 2nd edition
By: Current Partnering
... analysis of how and why companies enter asset purchase deals. The focus of the report is on partnerships for business, product, technology and royalty assets where partners have entered an agreement to dispose of or ...
|
more...
Search inside this report
|
11/1/2010
|
$2,695.00
|
|
Partnering Terms and Agreements in Diagnostics, 2nd edition
By: Current Partnering
... of how and why companies enter diagnostic partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors diagnostic technology or product candidates. ...
|
more...
Search inside this report
|
11/1/2010
|
$2,695.00
|
|
Drug Delivery Partnering Terms and Agreements in Pharma and Biotech, 2nd edition
By: Current Partnering
... a detailed understanding and analysis of how and why companies enter drug delivery partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license the ...
|
more...
Search inside this report
|
11/1/2010
|
$2,695.00
|
|
Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 4th Edition
By: Current Partnering
... This report provides details of the latest co-promotion and co-marketing agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully revised and updated, the report provides details of co-promotion and co-marketing agreements from 2003 to ...
|
more...
Search inside this report
|
10/1/2010
|
$2,495.00
|
|
Merger & Acquisition Terms & Agreements in Pharma, Biotech & Diagnostics, 4th Edition
By: Current Partnering
... revised and updated, the report provides details of merger and acquisition agreements from 2003 to early 2010. The report provides a detailed understand and analysis of how and why companies enter merger and acquisition deals. ...
|
more...
Search inside this report
|
10/1/2010
|
$2,695.00
|
|
Distribution partnering Terms & Agreements in Pharma, Biotech & Diagnostics, 3rd Edition
By: Current Partnering
... and analysis of how and why companies enter distribution deals.The majority of deals are multicomponent whereby the licensor offers a right to distribute the resultantproduct of the research collaboration. There are also numerous pure distribution ...
|
more...
Search inside this report
|
10/1/2010
|
$2,695.00
|
|
Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics, 3rd edition
By: Current Partnering
... report provides details of the latest manufacturing and supply agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully revised and updated, the report provides details of manufacturing and supply agreements from 2003 to early ...
|
more...
Search inside this report
|
10/1/2010
|
$2,695.00
|
|
Partnering Agreements with Bigpharma
By: Current Partnering
... to better understand bigpharma partnering. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources ...
|
more...
Search inside this report
|
10/1/2010
|
$2,695.00
|
|
Practical Guide to Finding Partners in Pharma and Biotech, 4th edition
By: Current Partnering
... reader through the practical steps required to prepare for partnering, prepare supporting materials, identify and shortlist potential partners and opportunities, identifying and contacting the right person in the partner company, and managing of discussions through ...
|
more...
Search inside this report
|
10/1/2010
|
$1,695.00
|
|
Title
|
Published
|
Price
|